Hijiya, N., Maschan, A., Rizzari, C., Shimada, H., Dufour, C., Goto, H., Kang, H. J., Guinipero, T., Karakas, Z., Bautista, F., Ducassou, S., Yoo, K. H., Zwaan, C. M., Millot, F., Patterson, B. C., Samis, J., Izquierdo, M., Titorenko, K., Li, S., & Sosothikul, D. (2023). The long-term efficacy and safety of nilotinib in pediatric patients with CML: a 5-year update of the DIALOG study. Blood Advances, 7(23), 7279–7289. https://doi.org/10.1182/bloodadvances.2023010122
Subjects:
Antineoplastic Agents
(MeSH)
Efficacy and Resistance in CML Treatment
(OpenAlex Topic)
Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia
(OpenAlex Topic)
mTOR Signaling in Growth and Disease
(OpenAlex Topic)
Publication Type:
Article
Unique ID:
10.1182/bloodadvances.2023010122
PMID:
Journal:
Publication Date:
Data Source:
OpenAlex
Source Link: